XenTech
Évry
About XenTech
XenTech is an innovative biotech/CRO company specialized in the preclinical cancer drug efficacy evaluation and the identification of biomarkers and therapeutic targets. They offer a unique collection of patient-derived tumor xenografts
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $764.0K
- Funding stage: Seed
- Last round: Seed (Oct 2008)
- Website: xentech.eu
- Phone: +33 (0)1 60 87 89 80
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/xentech-2956065 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.